Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Joseph P. Lynch$suffix/text()$suffix/text() & George G. Zhanel. (2023) Part 2: mucormycosis: focus on therapy. Expert Review of Anti-infective Therapy 21:7, pages 737-748.
Read now
Read now
Shrey Dwivedi, Princy Choudhary, Ayushi Gupta & Sangeeta Singh. (2023) The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Critical Reviews in Microbiology 49:3, pages 318-333.
Read now
Read now
Talia Serseg, Khedidja Benarous, Menaouar Serseg, Hafiz Muzzammel Rehman, Youness El Bakri & Souraya Goumri-Said. (2022) Discovery of inhibitors against SARS-CoV-2 associated fungal coinfections via virtual screening, ADMET evaluation, PASS, molecular docking, dynamics and pharmacophore studies. Arab Journal of Basic and Applied Sciences 29:1, pages 337-350.
Read now
Read now
Brian Shing, Mina Balen, James H. McKerrow & Anjan Debnath. (2021) Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs. Expert Review of Anti-infective Therapy 19:11, pages 1427-1441.
Read now
Read now
Elio Castagnola, Alessio Mesini, Carolina Saffioti, Sebastiano Barco, Roberto Bandettini, Sandro Dallorso, Giuliana Carrega, Maurizio Miano, Elena Palmisani & Carlo Dufour. (2020) Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation. Journal of Chemotherapy 32:4, pages 217-218.
Read now
Read now
Abdullah MS Al-Hatmi, G Sybren de Hoog & Jacques F Meis. (2019) Multiresistant Fusarium Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline?. Infection and Drug Resistance 12, pages 3727-3737.
Read now
Read now
Sameen Khalid, FNU Asad-ur -Rahman, Aamer Abbass, Sigfredo Aldarondo & Khalid Abusaada. (2017) Pseudomembranous aspergillar tracheobronchitis in a non-neutropenic critically ill patient in the intensive care unit. Journal of Community Hospital Internal Medicine Perspectives 7:1, pages 43-45.
Read now
Read now
Dustin T Wilson, V Paul Dimondi, Steven W Johnson, Travis M Jones & Richard H Drew. (2016) Role of isavuconazole in the treatment of invasive fungal infections. Therapeutics and Clinical Risk Management 12, pages 1197-1206.
Read now
Read now
Maria Aigner, Parul Chandorkar, Wolfgang Mutschlechner & Cornelia Lass-Flörl. (2016) Isavuconazole: an orphan drug for treating invasive candidiasis. Expert Opinion on Orphan Drugs 4:3, pages 333-342.
Read now
Read now
Monica A Donnelley, Elizabeth S Zhu & George R Thompson$suffix/text()$suffix/text(). (2016) Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infection and Drug Resistance 9, pages 79-86.
Read now
Read now
Suganthini Krishnan Natesan & Pranatharthi H Chandrasekar. (2016) Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations. Infection and Drug Resistance 9, pages 291-300.
Read now
Read now
Maria N Chitasombat & Dimitrios P Kontoyiannis. (2015) The ‘cephalosporin era’ of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections. Expert Opinion on Pharmacotherapy 16:10, pages 1543-1558.
Read now
Read now
David Allen, Dustin Wilson, Richard Drew & John Perfect. (2015) Azole antifungals: 35 years of invasive fungal infection management. Expert Review of Anti-infective Therapy 13:6, pages 787-798.
Read now
Read now
Lorena Botero-Calderon, Daniel K Benjamin$suffix/text()$suffix/text() & Michael Cohen-Wolkowiez. (2015) Advances in the treatment of invasive neonatal candidiasis. Expert Opinion on Pharmacotherapy 16:7, pages 1035-1048.
Read now
Read now
Seyedmojtaba Seyedmousavi, Paul E Verweij & Johan W Mouton. (2015) Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases. Expert Review of Anti-infective Therapy 13:1, pages 9-27.
Read now
Read now
Tyler Liebenstein & Jeannina A Smith. (2014) Current and future therapeutic strategies for treatment of blastomycosis. Expert Opinion on Orphan Drugs 2:4, pages 369-379.
Read now
Read now
Articles from other publishers (19)
Neelam Sharma, Shahid Nazir Wani, Tapan Behl, Sukhbir Singh, Ishrat Zahoor, Aayush Sehgal, Saurabh Bhatia, Ahmed Al-Harrasi, Lotfi Aleya & Simona Bungau. (2022) Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19. Environmental Science and Pollution Research 30:4, pages 9164-9183.
Crossref
Crossref
Arsa Thammahong. 2022. The Genus Aspergillus - Pathogenicity, Mycotoxin Production and Industrial Applications. The Genus Aspergillus - Pathogenicity, Mycotoxin Production and Industrial Applications.
Yan-Li Yang, Zi-Jian Xiang, Jing-Hua Yang, Wen-Jie Wang, Zhi-Chun Xu & Ruo-Lan Xiang. (2021) Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Farah Yasmin, Hala Najeeb, Aisha Naeem, Kartik Dapke, Rachana Phadke, Muhammad Sohaib Asghar, Syed Muhammad Ismail Shah, Domenico De Berardis & Irfan Ullah. (2021) COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management. Diseases 9:4, pages 65.
Crossref
Crossref
Malene Risum, Mai-Britt Vestergaard, Ulla Møller Weinreich, Marie Helleberg, Nadja Hawwa Vissing & René Jørgensen. (2021) Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole. Antibiotics 10:5, pages 487.
Crossref
Crossref
Gari Kasparyan, Chetan Poojari, Tomasz Róg & Jochen S. Hub. (2020) Cooperative Effects of an Antifungal Moiety and DMSO on Pore Formation over Lipid Membranes Revealed by Free Energy Calculations. The Journal of Physical Chemistry B 124:40, pages 8811-8821.
Crossref
Crossref
Hailin Zheng, Nana Song, Huan Mei, Jiacheng Dong, Dongmei Li, Xiaofang Li & Weida Liu. (2020)
In Vitro
Activities of Ravuconazole and Isavuconazole against Dematiaceous Fungi
. Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Crossref
Somanon Bhattacharya, Sutthichai Sae-Tia & Bettina C. Fries. (2020) Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics 9:6, pages 312.
Crossref
Crossref
Martin Schmidt-Hieber, Dan Engelhard, Andrew Ullmann, Per Ljungman, Johan Maertens, Rodrigo Martino, Montserrat Rovira, Peter J. Shaw, Christine Robin, Maura Faraci, Jenny Byrne, Kerstin Schäfer-Eckart, Hermann Einsele, Edgar Faber, Luigi Rigacci, Riccardo Saccardi, Aitana Balaguer-Rosello, Cecilia Isaksson, Maximilian Christopeit, Gloria Tridello, Junfeng Wang, Nina Knelange, Malgorzata Mikulska, Simone Cesaro & Jan Styczynski. (2019) Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT. Journal of Neurology 267:2, pages 430-439.
Crossref
Crossref
Anne Rain Tanner Brown, Michelle Horng & Terri Lynn Shigle. 2020. Oncologic Critical Care. Oncologic Critical Care
169
199
.
Elizabeth W. Tucker, Lisa Pieterse, Matthew D. Zimmerman, Zarir F. Udwadia, Charles A. Peloquin, Maria Tarcela Gler, Shashank Ganatra, Jeffrey A. Tornheim, Prerna Chawla, Janice C. Caoili, Brittaney Ritchie, Sanjay K. Jain, Véronique Dartois & Kelly E. Dooley. (2019) Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans. Antimicrobial Agents and Chemotherapy 63:10.
Crossref
Crossref
Frederic Ries, Astrid Alflen, Pamela Aranda Lopez, Hendrik Beckert, Matthias Theobald, Hansjörg Schild, Daniel Teschner & Markus Philipp Radsak. (2019) Antifungal Drugs Influence Neutrophil Effector Functions. Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Crossref
Anne Rain Tanner Brown, Michelle Horng & Terri Lynn Shigle. 2019. Oncologic Critical Care. Oncologic Critical Care
1
34
.
Allen S. W. Oak, John W. Baddley & Boni E. Elewski. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology
425
450
.
Connie R. Shi, Sarah N. Robinson, Avery LaChance, Martin C. Mihm Jr.Daniela Kroshinsky. (2017) A 53-Year-Old Male with Relapsed Diffuse Large B-Cell Lymphoma on Chemotherapy with a New Leg Lesion. Dermatopathology 4:1-4, pages 31-35.
Crossref
Crossref
Amit Desai, Laura Kovanda, Donna Kowalski, Qiaoyang Lu, Robert Townsend & Peter L. Bonate. (2016) Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi. Antimicrobial Agents and Chemotherapy 60:9, pages 5483-5491.
Crossref
Crossref
Yu Zhou, Jiang Wang, Zhanni Gu, Shuni Wang, Wei Zhu, José Luis Aceña, Vadim A. Soloshonok, Kunisuke Izawa & Hong Liu. (2016) Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. Chemical Reviews 116:2, pages 422-518.
Crossref
Crossref
Marina Y. Fosso, Sanjib K. Shrestha, Keith D. Green & Sylvie Garneau-Tsodikova. (2015) Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles. Journal of Medicinal Chemistry 58:23, pages 9124-9132.
Crossref
Crossref
Seyedmojtaba Seyedmousavi, Roger J. M. Brüggemann, Jacques F. Meis, Willem J. G. Melchers, Paul E. Verweij & Johan W. Mouton. (2015) Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model. Antimicrobial Agents and Chemotherapy 59:5, pages 2855-2866.
Crossref
Crossref